Published in J Invest Dermatol on September 22, 2014
Genetic variants in Hippo pathway genes YAP1, TEAD1 and TEAD4 are associated with melanoma-specific survival. Int J Cancer (2015) 0.90
Functional Variants in Notch Pathway Genes NCOR2, NCSTN, and MAML2 Predict Survival of Patients with Cutaneous Melanoma. Cancer Epidemiol Biomarkers Prev (2015) 0.87
Genetic variants in the PIWI-piRNA pathway gene DCP1A predict melanoma disease-specific survival. Int J Cancer (2016) 0.79
Genetic variants in the vitamin D pathway genes VDBP and RXRA modulate cutaneous melanoma disease-specific survival. Pigment Cell Melanoma Res (2016) 0.79
Vitamin D receptor polymorphisms and survival in patients with cutaneous melanoma: a population-based study. Carcinogenesis (2015) 0.78
Component-wise gradient boosting and false discovery control in survival analysis with high-dimensional covariates. Bioinformatics (2015) 0.78
Drug Survival Studies in Dermatology:Principles, Purposes, and Pitfalls. J Invest Dermatol (2015) 0.75
Genetic variants in the integrin signaling pathway genes predict cutaneous melanoma survival. Int J Cancer (2016) 0.75
Genetic Variants in the Genes Encoding Rho GTPases and Related Regulators Predict Cutaneous Melanoma-specific Survival. Int J Cancer (2017) 0.75
Inherited functional variants of the lymphocyte receptor CD5 influence melanoma survival. Int J Cancer (2016) 0.75
Cancer statistics, 2014. CA Cancer J Clin (2014) 72.81
Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics (1988) 70.41
MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol (2010) 26.41
Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol (2009) 23.08
Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst (2004) 19.00
GenABEL: an R library for genome-wide association analysis. Bioinformatics (2007) 18.10
The NCBI dbGaP database of genotypes and phenotypes. Nat Genet (2007) 17.93
Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol (2004) 5.49
SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. Nucleic Acids Res (2009) 5.40
How the fanconi anemia pathway guards the genome. Annu Rev Genet (2009) 4.94
Malignant melanoma: genetics and therapeutics in the genomic era. Genes Dev (2006) 4.24
The Fanconi Anemia/BRCA pathway: new faces in the crowd. Genes Dev (2005) 3.90
SLX4, a coordinator of structure-specific endonucleases, is mutated in a new Fanconi anemia subtype. Nat Genet (2011) 3.74
Fanconi anaemia and the repair of Watson and Crick DNA crosslinks. Nature (2013) 3.40
Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. Hum Mol Genet (2011) 2.26
Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity. Clin Cancer Res (2005) 2.09
SNPexp - A web tool for calculating and visualizing correlation between HapMap genotypes and gene expression levels. BMC Bioinformatics (2010) 1.81
The Fanconi anaemia pathway orchestrates incisions at sites of crosslinked DNA. J Pathol (2011) 1.68
Identification and validation of an anthracycline/cyclophosphamide-based chemotherapy response assay in breast cancer. J Natl Cancer Inst (2014) 1.66
Genetic variation in the DNA repair genes is predictive of outcome in lung cancer. Hum Mol Genet (2007) 1.32
Targeting EGFR induced oxidative stress by PARP1 inhibition in glioblastoma therapy. PLoS One (2010) 1.27
Alterations in candidate genes PHF2, FANCC, PTCH1 and XPA at chromosomal 9q22.3 region: pathological significance in early- and late-onset breast carcinoma. Mol Cancer (2008) 1.20
The role of ultraviolet radiation in melanomagenesis. Exp Dermatol (2010) 1.14
Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas. Mol Cancer (2009) 1.12
Polymorphisms of nucleotide excision repair genes predict melanoma survival. J Invest Dermatol (2013) 1.08
Melanoma prognosis: a REMARK-based systematic review and bioinformatic analysis of immunohistochemical and gene microarray studies. Mol Cancer Ther (2011) 1.04
DNA repair biomarkers predict response to neoadjuvant chemoradiotherapy in esophageal cancer. Int J Radiat Oncol Biol Phys (2011) 0.97
Significance of the Fanconi anemia FANCD2 protein in sporadic and metastatic human breast cancer. Am J Pathol (2010) 0.94
Melanoma risk loci as determinants of melanoma recurrence and survival. J Transl Med (2013) 0.94
Chromosomal changes characterize head and neck cancer with poor prognosis. J Mol Med (Berl) (2008) 0.92
Promoter hypermethylation of FANCF and outcome in advanced ovarian cancer. Br J Cancer (2008) 0.91
Influence of single nucleotide polymorphisms in the MMP1 promoter region on cutaneous melanoma progression. Melanoma Res (2012) 0.88
Upregulation of Fanconi anemia DNA repair genes in melanoma compared with non-melanoma skin cancer. J Invest Dermatol (2011) 0.87
Radiologic differences between bone marrow stromal and hematopoietic progenitor cell lines from Fanconi Anemia (Fancd2(-/-)) mice. Radiat Res (2014) 0.86
Loss of expression of FANCD2 protein in sporadic and hereditary breast cancer. Breast Cancer Res Treat (2007) 0.84
FANCJ expression predicts the response to 5-fluorouracil-based chemotherapy in MLH1-proficient colorectal cancer. Ann Surg Oncol (2012) 0.83
An exploration of pathways involved in lung carcinoid progression using gene expression profiling. Carcinogenesis (2013) 0.81
Sentinel lymph node biopsy for thin melanoma-con. J Surg Oncol (2012) 0.79
Inactivation of 9q22.3 tumor suppressor genes predict outcome for patients with head and neck squamous cell carcinoma. Anticancer Res (2013) 0.79
Do not underestimate nucleotide excision repair: it predicts not only melanoma risk but also survival outcome. J Invest Dermatol (2013) 0.79
Melanoma in patients younger than 20 years. G Ital Dermatol Venereol (2013) 0.77
FANCD2 mRNA overexpression is a bona fide indicator of lymph node metastasis in human colorectal cancer. Ann Surg Oncol (2010) 0.77
The role of sentinel lymph node biopsy for thin cutaneous melanomas of the head and neck. Am J Otolaryngol (2013) 0.76